policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…
JAVMA news
AAHA releases new guidelines on canine vaccination
The American Animal Hospital Association announced Sept. 5 that it has released new guidelines on canine vaccination.
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.